Get started
2seventy bio, Inc.22

2seventy bio, Inc.

4.95USDR
0.000.00%
At close at Mar 28, 23:01 GMT
USD
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

TSVT chart


Full chart

TSVT upcoming earnings


Next report date
≈
5 days ago
Report period
Q4 2024
EPS estimate
−0.19 USD
Revenue estimate
‪14.82 M‬ USD

Key stats


Market capitalization
‪255.36 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.83 USD
Net income (FY)
‪−217.57 M‬ USD
Revenue (FY)
‪100.39 M‬ USD
Shares float
‪47.46 M‬
Beta (1Y)
2.81

Employees


Employees (FY)
65
Change (1Y)
−209 −76.28%
Revenue / Employee (1Y)
‪582.49 K‬ USD
Net income / Employee (1Y)
‪−880.72 K‬ USD

About 2seventy bio, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
William Denise Baird
Website
2seventybio.com
Headquarters
Cambridge
Founded
2021
FIGI
BBG00YV1J622
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

Financials


Performance
‪−900%‬
‪−600%‬
‪−300%‬
‪0%‬
‪300%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−75.00 M‬‬
‪‪−50.00 M‬‬
‪‪−25.00 M‬‬
‪0.00‬
‪‪25.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−14.00 M‬‬
‪‪−7.00 M‬‬
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−14.00 M‬‬
‪‪−7.00 M‬‬
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−90.00 M‬‬
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−1.50‬
‪−1.00‬
‪−0.50‬
‪0.00‬
‪0.50‬
Actual
Estimate

TSVT news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TSVT is 4.95 USD — it hasn't changed in the past 24 hours. Watch 2seventy bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 2seventy bio, Inc. stocks are traded under the ticker TSVT.
TSVT stock hasn't changed in a week, the month change is a 84.70% rise, over the last year 2seventy bio, Inc. has showed a −7.99% decrease.
We've gathered analysts' opinions on 2seventy bio, Inc. future price: according to them, TSVT price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Watch TSVT chart and read a more detailed 2seventy bio, Inc. stock forecast: see what analysts think of 2seventy bio, Inc. and suggest that you do with its stocks.
TSVT reached its all-time high on Nov 4, 2021 with the price of 64.00 USD, and its all-time low was 1.54 USD and was reached on Nov 22, 2023. View more price dynamics on TSVT chart.
See other stocks reaching their highest and lowest prices.
TSVT stock is 0.20% volatile and has beta coefficient of 0.93. Track 2seventy bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is 2seventy bio, Inc. there?
Yes, you can track 2seventy bio, Inc. financials in yearly and quarterly reports right on TradingView.
2seventy bio, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
TSVT earnings for the last quarter are −0.37 USD per share, whereas the estimation was −0.20 USD resulting in a −82.72% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about 2seventy bio, Inc. earnings.
2seventy bio, Inc. revenue for the last quarter amounts to ‪2.93 M‬ USD, despite the estimated figure of ‪13.69 M‬ USD. In the next quarter, revenue is expected to reach ‪13.96 M‬ USD.
TSVT net income for the last quarter is ‪−19.52 M‬ USD, while the quarter before that showed ‪−9.93 M‬ USD of net income which accounts for −96.52% change. Track more 2seventy bio, Inc. financial stats to get the full picture.
No, TSVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 30, 2025, the company has 65 employees. See our rating of the largest employees — is 2seventy bio, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2seventy bio, Inc. EBITDA is ‪−98.45 M‬ USD, and current EBITDA margin is −260.01%. See more stats in 2seventy bio, Inc. financial statements.
Like other stocks, TSVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2seventy bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 2seventy bio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 2seventy bio, Inc. stock shows the buy signal. See more of 2seventy bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.